Browse > Article
http://dx.doi.org/10.5352/JLS.2010.20.4.602

Matrix Metalloproteinase-3 Gene Polymorphisms (A(-267)G, A658G, T813C) is Associated with Type 2 Diabetes in Koreans  

Yoo, Min (Department of Biology, College of Natural Sciences, Keimyung University)
Kim, Hyo-Jeong (Department of Biology, College of Natural Sciences, Keimyung University)
Qing, Ye (Department of Biology, College of Natural Sciences, Keimyung University)
Kim, Jong-Won (Department of Biology, College of Natural Sciences, Keimyung University)
Kim, Su-Won (Department of Biology, College of Natural Sciences, Keimyung University)
Publication Information
Journal of Life Science / v.20, no.4, 2010 , pp. 602-606 More about this Journal
Abstract
Type 2 diabetes is a typical polygenic disease complex, for which several common risk alleles have been identified. Proteins in the matrix metalloproteinase-3 (MMP3) family are involved in the breakdown of the extracellular matrix in normal physiological processes such as embryonic development, reproduction and tissue remodeling, as well as in disease processes. Therefore, we investigated the genotype for the A(-267)G, A658G and T813C polymorphisms in the MMP3 gene in the Korean population and compared genotypes of patients with those of the control group. 200 patients (male 108, female 92), who had previously been diagnosed with type 2 diabetes (T2DM) and 100 control subjects (male 36, female 64) participated in this study. There was a strong association between A(-267)G and A658G polymorphism in the MMP3 gene and T2DM. The present study shows that MMP3 polymorphisms (A(-267)G and A658G) may be associated with the pathogenesis of T2DM. Further studies with a larger population may be needed for the development of diagnostic methods at a genetic level, such as DNA chip.
Keywords
Type 2 Diabetes; matrix metalloproteinase-3 gene; polymorphism; DNA chip; Korean population;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Poollanen, P. J., T. Lehtimaki, E. Ilveskoski, J. Mikkelsson, O. A. Kajander, P. Laippala, M. Perola, S. Goebeler, A. Penttila, K. M. Mattila, K. Syrjakoski, T. Koivula, S. T. Nikkari, and P. J. Karhunen. 2002. Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study. Atherosclerosis 164, 329-335.   DOI
2 Reaven, G. M. 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607.   DOI
3 Robertson, W. B., J. P. Strong. 1968. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab. lnvest. 18, 538-551.
4 Ross, R. 1993. The pathogenesis of atherosclerosis; a perspective for the 1990s. Nature 362, 801-809.   DOI   ScienceOn
5 Schernthaner, G. 1996. Cardiovascular mortaality and morbidity in type-2 diabetes mellitus. Diabetes Res. Clin. Pract. 31, Suppl. S3-13.   DOI
6 Fukuyama, K., T. Ohara, Y. Hirota, K. Maeda, S. Kuno, M. Zenibayashi, T. Teranishi, K. Kouyama, E. Maeda, N. Sakamoto, and M. Ksauga. 2006. Association of the -112a>c polymorphism of the uncoupling protein 1 gene with insulin resistance in Japanese individuals with type 2 diabetes. Biochem. Biophys. Res. Commun. 339, 1212-1216.   DOI
7 Gloyn, A. L., Y. Hashim, S. J. Aschcroft, R. Ashfield, S. Wiltshire, and R. C. Turmer. 2001. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with type 2 diabetes mellitus (UKPDS 53). Diabet. Med. 18, 206-212.   DOI
8 Goldbourt, U. and H. N. Neufeld. 1986. Genetic aspects of arteriosclerosis. Arteriosclerosis 6, 357-377.   DOI
9 Groop, L., C. Forsblom, M. Lehtovirta, T. Tuomi, S. Karanko, M. Nissen, B. O. Ehrnstrom, B. Forsen, B. Isomaa, B. Snickars, and M. R. Taskinen. 1996. Metabolic consequences of family history of NIDDM (The Botnia Study). Diabetes 45, 1585-1593.   DOI
10 Chung, A. W. Y., H. Luo, T. Tejerina, C. V. Breemena, and E. B. Okon. 2007. Enhanced cell cycle entry and mitogen-activated protein kinase-signaling and down regulation of matrix metalloproteinase-1 and -3 in human diabetic arterial vasculature. Atherosclerosis 195, 1-8.   DOI
11 Doney, A. S., B. Fischer, J. E. Cecil, K. Boylan, F. E. McGuigan, S. H. Ralston, A. D. Morris, and C. N. Palmer. 2004. Association of the pro12ala and c1431t variants of PPARg and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47, 555-558.   DOI
12 Egeblad, M. and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2, 161-174.   DOI
13 Ferrara, N. 2001. Role of vasclar endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 280, 1358-1366.
14 Lee, J. E., Y. K. Choi, H. A. Seo, J. H. Jeong, J. Y. Jeong, S. S. Moon, J. G. Kim, B. W. Kim, S. W. Kim, M. Yoo, J. Y. Kim, and I. K. Lee. 2010. Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetesin a Korean population. Diabetes Res. and Clin. Prac. 88, 87-96.   DOI
15 Grundy, S. M. 1999. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am. J. Cardiol. 83, 25F-29F.
16 Hojilla, C. V., F. F. Mohammed, and R. Khokha. 2003. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. British J. Cancer 89, 1817-1821.   DOI
17 Hu, F. B. and A. Doria. 2004. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 53, 209-213.   DOI
18 Ye, S. 2006. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovascular Research 69, 636-645.   DOI
19 Stimvoll, M., B. J Goldstein, and T. W. van Gaeften. 2005. Type 2 diabetes; principles of pathogenesis and therapy. Lacet 365, 1333-1346.
20 Wang, H., and J. A. Keiser. 1998. Vascular endothelial growth factor upregulatesthe expression of matrix metalloproteinase in vascular smooth muscle cells; role of flt-1. Circ. Res. 83, 832-840.   DOI   ScienceOn
21 Zhang, C., L. Qi, D. J. Humter, J. B. Meigs, J. E. Manson, R. M. van Dam, and F. B. Hu. 2006. Variant of transcription factor 7-like 2 (tcf7l2) gene and the risk of type 2 diabetes in large cohorts of U. S. Women and men. Diabetes 55, 2645-2648.   DOI
22 Zimmet, P. 2002. Addressing the insulin resistance syndrome. TCM. 12, 354-362.
23 Nam, J. H. and K. S. Park. 2004. Single nucleotide polymorphisms of matrix metalloproteinase in Koreans. Kor. J. Genetics 26, 289-296.
24 Medley, T. L., B. A. Kingwell, C. D. Gatzka, P. Pillay, and T. J. Cole. 2003. Matrix metallopreteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ. Res. 92, 1254-1261.   DOI
25 Mensah, G. A., A. H. Mokdad, E. Ford, K. M. Narayan, W. H. Giles, F. Vinicor, and P. C. Deedwania. 2004. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implication. Cardiol. Clin. 22, 485-504.   DOI
26 Musi, N. 2006. AMP-activated protein kinase and type 2 diabetes. Curr. Med. Chem. 13, 583-589.   DOI
27 Newby, A. C. 2005. Dual role of matrix metalloproteinases in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85, 1-31.   DOI